Should residents’ access to Alzheimer’s drug be restricted?
By
Lois A. Bowers
Jan 18, 2022
You have until Feb. 10 to share your comments with CMS about its recent proposal related to Alzheimer’s drug aducanumab (Aduhelm).
A very troubling $56 billion question
By
John O'Connor
Jul 08, 2021
Considering some of the alternatives, I’m far from convinced that bankrupting Medicare for the sake of Aduhelm would be money well spent.
Reason for hope as World Alzheimer’s Month continues
By
Lois A. Bowers
Sep 23, 2019
Days before World Alzheimer’s Day, which was Saturday, some bad news arrived about the search for a treatment. But there still are reasons for hope in the battle against Alzheimer’s.
Seeing is believing when it comes to Alzheimer’s effects
By
Lois A. Bowers
Apr 23, 2018
It’s quite something to see the 10-year progression of Alzheimer’s disease in one person collapsed into a 13-minute TV segment.
Alzheimer’s film: Not many surprises for you, but maybe some for general public
By
Lois A. Bowers
Jan 30, 2017
Those who care for residents with Alzheimer’s disease every day shouldn’t expect many surprises from a new PBS documentary, “Alzheimer’s: Every Minute Counts.” But you still...